In many cases, people volunteer because existing drugs are not helping their cancer, schizophrenia or other condition, Olfson said, and may have forms of the disease where it is harder for a drug to demonstrate a benefit.Another explanation could be that the scientific quality of clinical trials has improved over the decades, as the Health Affairs analysis found.